Preclinical and Drug Discovery CRO
REPROCELL Biopta’s human tissue technology predicts clinical success by using the closest possible model of drug behavior in humans.
Human tissue testing is a translational approach to drug discovery that bridges the gap between animal studies and clinical trials — increasing clinical success rates and adding commercial value to preclinical drug assets through proof of concept in patient-derived living tissues.
REPROCELL Biopta™ – the human tissue experts
Trusted by top Pharma
Drug Discovery Assay Catalog
REPROCELL Biopta is home to the world’s first and largest human fresh tissue assay catalog. In this digital platform, you can filter our assays by tissue type, endpoint, receptor, platform technology, drug type, and more.
Human tissue assay types
This invaluable information allows you to make ‘go’ or ‘no-go’ decisions with greater confidence, based on human data generated in biospecimens sourced from the target patient population.
Examples of our work
Our expertise in all areas of human tissue testing – including ethics, sourcing, handling, and fee-for-service experiments in human fresh tissue – allows us to act as your human tissue research department.
IPM Case Study
Achieve regulatory approval
When IPM approached the regulators for approval of their HIV prevention ring, they requested additional data on uterine contractility. Find out how our studies in fresh human uterine tissue helped IPM gain approval.
Amgen Case Study
Avoid species differences
Read our case study on Amgen's publication, which highlights the useful comparisons that can be made between matched tissues from preclinical species and humans.
Why use human tissue?
Managing risks and saving money in drug discovery
Human fresh tissue can be used to manage risk and save money across the entire drug discovery pipeline.
Demonstrating efficacy and safety at every phase of drug discovery
Human fresh tissue can be used in all phases of drug discovery programs, from target validation to clinical trouble shooting.
Join our human tissue supplier network
We are investing in our tissue network to meet the growing safety and efficacy requirements of drug development programs and medicine regulators around the globe.
Our human tissue platform technologies
At REPROCELL, we offer a unique range of experimental techniques for translating data from preclinical species to humans.
Tissue Baths and Wire Myographs
Explore nerve-muscle interactions and the contractility of smooth, cardiac, or skeletal muscles.
Ex vivo Tissue Culture
Measure a range of functional endpoints including cytokine production and gene expression.
Preclinical & Drug Discovery CRO